Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure-Reference-Cited by-同舟云学术

Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure

Published:2020-08-05 Issue:9 Volume:63 Page:911-920
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Arastehfar Amir¹²^ORCID,Daneshnia Farnaz¹^ORCID,Salehi Mohammadreza³,Yaşar Melike⁴^ORCID,Hoşbul Tuğrul⁵^ORCID,Ilkit Macit⁶^ORCID,Pan Weihua¹^ORCID,Hagen Ferry²⁷⁸^ORCID,Arslan Nazlı⁹^ORCID,Türk‐Dağı Hatice¹⁰^ORCID,Hilmioğlu‐Polat Süleyha⁴^ORCID,Perlin David S.¹¹,Lass‐Flörl Cornelia¹²^ORCID

Affiliation:

1. Shanghai Key Laboratory Molecular Medical Mycology Shanghai China

2. Westerdijk Fungal Biodiversity Institute Utrecht The Netherlands

3. Department of Infectious Diseases and Tropical Medicine Faculty of Medicine Tehran University of Medical Sciences Tehran Iran

4. Department of Medical Microbiology Faculty of Medicine Ege University Izmir Turkey

5. Department of Medical Microbiology Gulhane Training and Research Hospital University of Health Sciences Ankara Turkey

6. Division of Mycology Faculty of Medicine Çukurova University Adana Turkey

7. University Medical Center Utrecht Utrecht The Netherlands

8. People's Hospital Jining China

9. Department of Medical Microbiology Dokuz Eylül University Faculty of Medicine Izmir Turkey

10. Department of Microbiology Faculty of Medicine Selcuk University Konya Turkey

11. Center for Discovery and Innovation Hackensack Meridian Health Nutley NJ USA

12. Division of Hygiene and Medical Microbiology Medical University of Innsbruck Innsbruck Austria

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13104

Reference61 articles.

1. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population‐based surveillance studies in two U.S. cities from 2008 to 2011;Lockhart SR;J Clin Microbiol,2008

2. Epidemiology of candidemia at a tertiary Canadian hospital, 2004–2013;Remington TL;Can J Infect Dis Med Microbiol,2018

3. Changing epidemiology of candidaemia in Australia

4. Clinical and microbiological factors associated with mortality in candidemia in adult patients 2007–2016

5. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implication of genotypes for prognosis of Candida glabrata bloodstream infections;Journal of Antimicrobial Chemotherapy;2024-06-22

2. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease;Clinical Microbiology Reviews;2024-06-13

3. Candida glabrata hospital isolate from Lebanon reveals micafungin resistance associated with increased chitin and resistance to a cell-surface-disrupting agent;Journal of Global Antimicrobial Resistance;2024-06

4. Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List;Medical Mycology;2024-06

5. Echinocandin persistence directly impacts the evolution of resistance and survival of the pathogenic fungus Candida glabrata;mBio;2024-04-10